構造的心疾患向けオクルーダーのパイプライン - 開発段階、セグメント、地域、規制経路、主要企業

当レポートでは、構造的心疾患向けオクルーダーのパイプライン製品について調査分析し、さまざまな開発段階にある製品の比較分析や、進行中の臨床試験のデータを含む、包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

• 構造的心疾患向けオクルーダー - パイプライン製品：開発段階別
• 構造的心疾患向けオクルーダー - パイプライン製品：セグメント別
• 構造的心疾患向けオクルーダー - パイプライン製品：地域別
• 構造的心疾患向けオクルーダー - パイプライン製品：規制経路別
• 構造用心臓オクルーダー - パイプライン製品：推定承認日別
• 構造的心疾患向けオクルーダー - 進行中の臨床試験

第4章 構造型心臓オクルーダー - 開発中のパイプライン製品：企業別

• 構造的心疾患向けオクルーダー企業 - パイプライン製品：開発段階別
• 構造的心疾患向けオクルーダー - パイプライン製品：開発段階別

第5章 構造的心疾患向けオクルーダーの企業と製品の概要

• Abbott Japan Co Ltd：企業の概要
  • Abbott Japan Co Ltd：パイプライン製品と進行中の臨床試験の概要
• Aegis Medical Innovations Inc.：企業の概要
  • Aegis Medical Innovations Inc.：パイプライン製品と進行中の臨床試験の概要
• Aporo Biomedical, Inc.（休止中）：企業の概要
  • Aporo Biomedical, Inc.（休止中）：パイプライン製品と進行中の臨床試験の概要
• Append Medical：企業の概要
  • Append Medical：パイプライン製品と進行中の臨床試験の概要
• atHeart Medical：企業の概要
  • atHeart Medical：パイプライン製品と進行中の臨床試験の概要
• AuriGen Medical Ltd：企業の概要
  • AuriGen Medical Ltd：パイプライン製品と進行中の臨床試験の概要
• Boston Scientific Corp：企業の概要
  • Boston Scientific Corp：パイプライン製品と進行中の臨床試験の概要
• CARAG AG：企業の概要
  • CARAG AG：パイプライン製品と進行中の臨床試験の概要
• Cierra, Inc.（休止中）：企業の概要
  • Cierra, Inc.（休止中）：パイプライン製品と進行中の臨床試験の概要
• Conformal Medical Inc：企業の概要
  • Conformal Medical Inc：パイプライン製品と進行中の臨床試験の概要
• Cor Habere Corp：企業の概要
  • Cor Habere Corp：パイプライン製品と進行中の臨床試験の概要
• Dextera Surgical Inc：企業の概要
  • Dextera Surgical Inc：パイプライン製品と進行中の臨床試験の概要
• Endomimetics LLC：企業の概要
  • Endomimetics LLC：パイプライン製品と進行中の臨床試験の概要
• Ension, Inc.：企業の概要
  • Ension, Inc.：パイプライン製品と進行中の臨床試験の概要
• Guangdong Pulse Medical Technology Co Ltd：企業の概要
  • Guangdong Pulse Medical Technology Co Ltd：パイプライン製品と進行中の臨床試験の概要
• Hangzhou Dinova EP Technology Co Ltd：企業の概要
  • Hangzhou Dinova EP Technology Co Ltd：パイプライン製品と進行中の臨床試験の概要
• Hansen Medical Inc（休止中）：企業の概要
  • Hansen Medical Inc（休止中）：パイプライン製品と進行中の臨床試験の概要
• Jenscare Scientific Co Ltd：企業の概要
  • Jenscare Scientific Co Ltd：パイプライン製品と進行中の臨床試験の概要
• Laminar Inc：企業の概要
  • Laminar Inc：パイプライン製品と進行中の臨床試験の概要
• Lepu Scientech Medical Technology (Shanghai) Co Ltd：企業の概要
  • Lepu Scientech Medical Technology (Shanghai) Co Ltd：パイプライン製品と進行中の臨床試験の概要
• Lifetech Scientific (Shenzhen) Co Ltd：企業の概要
  • Lifetech Scientific (Shenzhen) Co Ltd：パイプライン製品と進行中の臨床試験の概要
• LuSeed Vascular：企業の概要
  • LuSeed Vascular：パイプライン製品と進行中の臨床試験の概要
• Mayo Clinic：企業の概要
  • Mayo Clinic：パイプライン製品と進行中の臨床試験の概要
• Medtronic Plc：企業の概要
  • Medtronic Plc：パイプライン製品と進行中の臨床試験の概要
• Micro Interventional Devices, Inc.：企業の概要
  • Micro Interventional Devices, Inc.：パイプライン製品と進行中の臨床試験の概要
• Northwestern University：企業の概要
  • Northwestern University：パイプライン製品と進行中の臨床試験の概要
• Occlutech International AB：企業の概要
  • Occlutech International AB：パイプライン製品と進行中の臨床試験の概要
• SentreHEART Inc：企業の概要
  • SentreHEART Inc：パイプライン製品と進行中の臨床試験の概要
• SeptRx, Inc.（休止中）：企業の概要
  • SeptRx, Inc.（休止中）：パイプライン製品と進行中の臨床試験の概要
• Shanghai Shenqi Medical Technology Co Ltd：企業の概要
  • Shanghai Shenqi Medical Technology Co Ltd：パイプライン製品と進行中の臨床試験の概要
• Swissimplant AG：企業の概要
  • Swissimplant AG：パイプライン製品と進行中の臨床試験の概要
• The Chaim Sheba Medical Center：企業の概要
  • The Chaim Sheba Medical Center：パイプライン製品と進行中の臨床試験の概要
• University of Minnesota：企業の概要
  • University of Minnesota：パイプライン製品と進行中の臨床試験の概要
• Vascular Closure Systems Inc：企業の概要
  • Vascular Closure Systems Inc：パイプライン製品と進行中の臨床試験の概要
• Vascular Concepts Ltd：企業の概要
  • Vascular Concepts Ltd：パイプライン製品と進行中の臨床試験の概要
• W. L. Gore & Associates Inc：企業の概要
  • W. L. Gore & Associates Inc：パイプライン製品と進行中の臨床試験の概要
• Worry Free Beating：企業の概要
  • Worry Free Beating：パイプライン製品と進行中の臨床試験の概要

第6章 構造的心疾患向けオクルーダー - 近年の発展

第7章 付録

List of Tables

List of Tables

• Structural Heart Occluders - Pipeline Products by Stage of Development
• Structural Heart Occluders - Pipeline Products by Segment
• Structural Heart Occluders - Pipeline Products by Territory
• Structural Heart Occluders - Pipeline Products by Regulatory Path
• Structural Heart Occluders - Pipeline Products by Estimated Approval Date
• Structural Heart Occluders - Ongoing Clinical Trials
• Structural Heart Occluders Companies - Pipeline Products by Stage of Development
• Structural Heart Occluders - Pipeline Products by Stage of Development
• Glossary

List of Figures

List of Figures

• Structural Heart Occluders - Pipeline Products by Stage of Development
• Structural Heart Occluders - Pipeline Products by Segment
• Structural Heart Occluders - Pipeline Products by Territory
• Structural Heart Occluders - Pipeline Products by Regulatory Path
• Structural Heart Occluders - Pipeline Products by Estimated Approval Date
• Structural Heart Occluders - Ongoing Clinical Trials

Abstract

GlobalData's Medical Devices sector report, "Structural Heart Occluders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Structural Heart Occluders pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Structural heart occluders are used for treatment congenital heart defects by closing openings in the heart. Structural heart occluders covers left atrial appendage closure devices, atrial septal defect occluders, ventricular septal defect occluders, patent foramen ovale closure devices, patent ductus arteriosus closure devices.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Structural Heart Occluders under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Structural Heart Occluders and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Structural Heart Occluders under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Structural Heart Occluders Overview

3 Products under Development

• 3.1 Structural Heart Occluders - Pipeline Products by Stage of Development
• 3.2 Structural Heart Occluders - Pipeline Products by Segment
• 3.3 Structural Heart Occluders - Pipeline Products by Territory
• 3.4 Structural Heart Occluders - Pipeline Products by Regulatory Path
• 3.5 Structural Heart Occluders - Pipeline Products by Estimated Approval Date
• 3.6 Structural Heart Occluders - Ongoing Clinical Trials

4 Structural Heart Occluders - Pipeline Products under Development by Companies

• 4.1 Structural Heart Occluders Companies - Pipeline Products by Stage of Development
• 4.2 Structural Heart Occluders - Pipeline Products by Stage of Development

5 Structural Heart Occluders Companies and Product Overview

• 5.1 Abbott Japan Co Ltd Company Overview
  • 5.1.1 Abbott Japan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Aegis Medical Innovations Inc. Company Overview
  • 5.2.1 Aegis Medical Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Aporo Biomedical, Inc. (Inactive) Company Overview
  • 5.3.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 Append Medical Company Overview
  • 5.4.1 Append Medical Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 atHeart Medical Company Overview
  • 5.5.1 atHeart Medical Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 AuriGen Medical Ltd Company Overview
  • 5.6.1 AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Boston Scientific Corp Company Overview
  • 5.7.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 CARAG AG Company Overview
  • 5.8.1 CARAG AG Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Cierra, Inc. (Inactive) Company Overview
  • 5.9.1 Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Conformal Medical Inc Company Overview
  • 5.10.1 Conformal Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Cor Habere Corp Company Overview
  • 5.11.1 Cor Habere Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Dextera Surgical Inc Company Overview
  • 5.12.1 Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Endomimetics LLC Company Overview
  • 5.13.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Ension, Inc. Company Overview
  • 5.14.1 Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Guangdong Pulse Medical Technology Co Ltd Company Overview
  • 5.15.1 Guangdong Pulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Hangzhou Dinova EP Technology Co Ltd Company Overview
  • 5.16.1 Hangzhou Dinova EP Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Hansen Medical Inc (Inactive) Company Overview
  • 5.17.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Jenscare Scientific Co Ltd Company Overview
  • 5.18.1 Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 Laminar Inc Company Overview
  • 5.19.1 Laminar Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 Lepu Scientech Medical Technology (Shanghai) Co Ltd Company Overview
  • 5.20.1 Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
  • 5.21.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 LuSeed Vascular Company Overview
  • 5.22.1 LuSeed Vascular Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 Mayo Clinic Company Overview
  • 5.23.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 Medtronic Plc Company Overview
  • 5.24.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.25 Micro Interventional Devices, Inc. Company Overview
  • 5.25.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.26 Northwestern University Company Overview
  • 5.26.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
• 5.27 Occlutech International AB Company Overview
  • 5.27.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
• 5.28 SentreHEART Inc Company Overview
  • 5.28.1 SentreHEART Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.29 SeptRx, Inc. (Inactive) Company Overview
  • 5.29.1 SeptRx, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.30 Shanghai Shenqi Medical Technology Co Ltd Company Overview
  • 5.30.1 Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.31 Swissimplant AG Company Overview
  • 5.31.1 Swissimplant AG Pipeline Products & Ongoing Clinical Trials Overview
• 5.32 The Chaim Sheba Medical Center Company Overview
  • 5.32.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
• 5.33 University of Minnesota Company Overview
  • 5.33.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
• 5.34 Vascular Closure Systems Inc Company Overview
  • 5.34.1 Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.35 Vascular Concepts Ltd Company Overview
  • 5.35.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.36 W. L. Gore & Associates Inc Company Overview
  • 5.36.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.37 Worry Free Beating Company Overview
  • 5.37.1 Worry Free Beating Pipeline Products & Ongoing Clinical Trials Overview

6 Structural Heart Occluders- Recent Developments

• 6.1 Nov 13, 2023: Jenscare : Simulock Successfully Completes Implantation Surgery for the First Confirmatory Clinical Trial
• 6.2 Oct 24, 2023: Conformal Medical Announces Compelling One-Year Data from its Left Atrial Appendage Occlusion (LAAO) Early Feasibility Study
• 6.3 Oct 17, 2023: The Gore Relief Clinical Study Begins Randomizing Patients to Evaluate PFO Closure for Migraine Headache Relief
• 6.4 Sep 07, 2023: Boston Scientific's LAAC device gets FDA approval
• 6.5 Sep 06, 2023: Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device
• 6.6 May 17, 2023: MicroPort's LAA closure AnchorMan device achieves primary endpoint from SAFE PROTECT clinical trial, showing very promising results
• 6.7 Feb 27, 2023: Study demonstrates successful device size selection when assessing left atrial appendage by angiography compared to TEE
• 6.8 Jan 31, 2023: Conformal Medical announces positive one-year data from its left atrial appendage closure performed under conscious sedation study
• 6.9 Jan 05, 2023: JSCAI publishes peer-reviewed article highlighting effective performance of conformal medical's Left Atrial Appendage (CLAAS) Device
• 6.10 Dec 06, 2022: Henry Ford Health to lead first-of-its-kind national trial for innovative heart device

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer